Previous Section
Review Articles
11. Controversies in the front-line management of chronic lymphocytic leukemia.
- Author
- Nabhan C; Shanafelt TD; Kay NE;
- Institution
- Oncology Specialists, S. C., Lutheran General Hospital, Department of Medicine, Division of Hematology and Medical Oncology, Park Ridge, IL 60068, USA. cnabhan@oncmed.net
- Journal
- Leuk Res. 2008 May;32(5):679-88. Epub 2008 Jan 11.
- Abstract URL
- Click here to view abstract
12. Chronic lymphocytic leukaemia.
- Author
- Dighiero G; Hamblin TJ;
- Institution
- Institut Pasteur de Montevideo, Montevideo, Uruguay.
- Journal
- Lancet. 2008 Mar 22;371(9617):1017-29.
- Abstract URL
- Click here to view abstract
13. Alemtuzumab in the treatment of chronic lymphocytic lymphoma.
- Author
- Boyd K; Dearden CE;
- Institution
- The Royal Marsden Hospital and Institute of Cancer Research, London, UK. kboyd@doctors.org.uk
- Journal
- Expert Rev Anticancer Ther. 2008 Apr;8(4):525-33.
- Abstract URL
- Click here to view abstract
14. The role of prognostic factors in assessing 'high-risk' subgroups of patients with chronic lymphocytic leukemia.
- Author
- Kay NE; O'Brien SM; Pettitt AR; Stilgenbauer S;
- Institution
- Division of Hematology, Mayo Clinic, Rochester, MN, USA. kay.neil@mayo.edu
- Journal
- Leukemia. 2007 Sep;21(9):1885-91. Epub 2007 Jun 14.
- Abstract URL
- Click here to view abstract
15. Chronic lymphocytic leukemia.
- Author
- Ghia P; Ferreri AM; Galigaris-Cappio F;
- Institution
- Department of Oncology, Universita' Vita-Salute San Raffaele, San Raffaele Scientific Institute, Milan, Italy. ghia.paolo@hsr.it
- Journal
- Crit Rev Oncol Hematol. 2007 Dec;64(3):234-46. Epub 2007 Jun 1.
- Abstract URL
- Click here to view abstract
16. Intrinsic and treatment-related immune alterations in chronic lymphocytic leukaemia and their impact for clinical practice.
- Author
- Dasanu CA;
- Institution
- Seattle Hematology-Oncology, 2202 70th Ave West, University Place, WA 98466, USA. c_dasanu@yahoo.com
- Journal
- Expert Opin Pharmacother. 2008 Jun;9(9):1481-94.
- Abstract URL
- Click here to view abstract
17. Lenalidomide for the treatment of B-cell malignancies.
- Author
- Chanan-Khan AA; Cheson BD; Chanan-Khan AA; Cheson BD;
- Institution
- Roswell Park Cancer Institute, Buffalo, NY, USA. asher.chanan-khan@roswellpark.org
- Journal
- J Clin Oncol. 2008 Mar 20;26(9):1544-52. Epub 2008 Feb 19.
- Abstract URL
- Click here to view abstract
18. Novel monoclonal antibodies for the treatment of chronic lymphocytic leukemia.
- Author
- Robak T;
- Institution
- Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, 93-510 Lodz, ul. Ciolkowskiego 2, Poland. robaktad@csk.umed.lodz.pl
- Journal
- Curr Cancer Drug Targets. 2008 Mar;8(2):156-71.
- Abstract URL
- Click here to view abstract
19. Chronic lymphocytic leukemia: diagnosis and treatment.
- Author
- Yee KW; O'Brien SM;
- Institution
- Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
- Journal
- Mayo Clin Proc. 2006 Aug;81(8):1105-29.
- Abstract URL
- Click here to view abstract
20. Fludarabine in chronic lymphocytic leukaemia.
- Author
- Elter T; Hallek M; Engert A;
- Institution
- First Department of Internal Medicine, University of Cologne, Joseph-Stelzmann-Str. 9, 50924 Cologne, Germany. thomas.elter@uk-koeln.de
- Journal
- Expert Opin Pharmacother. 2006 Aug;7(12):1641-51.
- Abstract URL
- Click here to view abstract
